VARIABLE BMI < 21 (n=20) BMI 21-30 (n=128) BMI > 30 (n=28) P
LDL-C 107 (69, 133) 108 (81, 137) 98 (84, 119) 0.82
Triglycerides 131 (90, 178) 125 (78, 207) 138 (87, 250) 0.47
RLP-C 9.7 (6.4, 14.7) 8.8 (6.5, 15.6) 8.1 (5.9, 21.6) 0.75
NEFA (mEq/L) 0.3 (0.2, 0.5) 0.3 (0.2, 0.5) 0.4 (0.3, 0.5) 0.076
Apo-B 81 ± 22 85 ± 22 84 ± 19 0.72
Lp(a) 8 (1, 27) 19 (8, 52) 14 (6, 29) 0.046
HDL-C 34 (27, 50) 37 (30, 48) 37 (27, 46) 0.94
HDL-TG 23 (14, 26) 17 (11, 21) 18 (12, 26) 0.27
ApoA-I 121 ± 26 126 ± 28 126 ± 30 0.67
ApoA-II 36 ± 10 35 ± 10 32 ± 8 0.36
ApoE 4.3 (3.6, 5.5) 4.0 (3.4, 5.1) 4.3 (3.5, 6.9) 0.47
Preβ-1 32 (24, 43) 37 (30, 46) 36 (28, 46) 0.41
Preβ-2 1.7 (1.7, 2.2) 1.5 (1.0, 2.8) 2.1 (1.0, 3.6) 0.48
α-1 10 (6, 17) 10 (6, 16) 11(8, 20) 0.43
α-2 26 (23, 40) 28 (22, 35) 28 (23, 37) 0.96
α-3 22 (17, 29) 23 (18, 28) 21 (17, 25) 0.45
α-4 7 (6, 8) 7 (5, 9) 6 (5, 11) 0.97
Preα-1 2 (1, 4) 2 (1, 5) 3 (1, 8) 0.49
Preα-2 4 (2, 6) 3 (2, 4) 5 (2, 6) 0.22
Preα-3 3 (1, 4) 3 (2, 4) 3 (2, 4) 0.94
Preα-4 1.2 (0.6, 1.7) 1.1 (0.7, 1.5) 1.4 (0.6, 1.8) 0.39
CETP (μg/mL) 2 (2, 3) 2 (2, 3) 2 (2, 3) 0.99
LCAT (μg/mL) 7 (6, 9) 7 (6, 8) 7 (6, 8) 0.94
CETP Activity (μg/mL/hour) 0.9 (0.2, 2.4) 0.3 (-1.3, 1.8) 0.3 (-1.4, 1.8) 0.53
LCAT Activity (μg/mL/hour) 17 (11, 27) 17 (10, 28) 13 (11, 21) 0.59
Values are mg/dL or as indicated.
Normally distributed parameters are expressed as average ± SD.
Not normally distributed parameters are expressed as median (min, max).
Table 5b: Lipoprotein-associated parameters in patients, tertiled by BMI.
Goto home»